Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2002
07/11/2002US20020090694 Human Hox C10 and polynucleotides encoding
07/11/2002US20020090693 Novel human sodium-dependent phosphate cotransporter
07/11/2002US20020090687 Process for the production of polyhydroxyoctanoate by streptomyces lividans
07/11/2002US20020090685 Nucleotide sequences coding for the ndkA gene
07/11/2002US20020090684 Racemization of preferential amino acids; obtain chemical intermediate, incubate with preferential enzyme, recover amino acid
07/11/2002US20020090679 Lung growth factor variant
07/11/2002US20020090678 Generating preferential polypeptide; obtain cells, incubate with expression vector containing preferential gene, express vector, recover polypeptide
07/11/2002US20020090675 Process for producing transglutaminase
07/11/2002US20020090673 Nucleic acids, proteins, and antibodies
07/11/2002US20020090672 Nucleic acids, proteins, and antibodies
07/11/2002US20020090671 Bone stimulating factor
07/11/2002US20020090660 Helicobacter pylori antigens in blood
07/11/2002US20020090654 Polypeptide for use in the treatment of collagenase defects
07/11/2002US20020090651 Isolated FGF receptor
07/11/2002US20020090648 Protein design automation for protein libraries
07/11/2002US20020090647 Peptide for use in treatment of nervous system disorders
07/11/2002US20020090637 Differential phage capture proteomics
07/11/2002US20020090636 Screening nucleotide sequences samples; obtain nucleotide sequences, incubate with primers, amplify nucleotide sequences, analyzing amplified nucleotide sequences
07/11/2002US20020090635 Compositions and methods for the release of nucleic acid molecules from solid matrices
07/11/2002US20020090634 Sequence determination of preferential nucleotide sequences; obtain nuclelotide sequences, electrophorese, determine sequence of nucleic acids
07/11/2002US20020090633 Molecular torches
07/11/2002US20020090630 Method of sequence determination for nucleic acid
07/11/2002US20020090629 Digital amplification
07/11/2002US20020090624 Gene markers useful for detecting skin damage in response to ultraviolet radiation
07/11/2002US20020090623 Isolating nucleotide sequences from filter; obtain filter, lyse cells which are retain on filter, remove lysate from filter, rupture leukocyte nucleus, recover and analyze nuceotide sequences
07/11/2002US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control
07/11/2002US20020090616 Electrophretic probes for detection and monitoring ligand binding activity
07/11/2002US20020090612 Detection of preferential nucleotide sequences in sample; obtain sample, incubate with probes, record pattern, compare to control
07/11/2002US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease
07/11/2002US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections
07/11/2002US20020090606 Generating immunocompetent phage pools; obtain animal, inject with antigen, withdraw blood from animal, incubate blood with solid support containing binding agent, recover cells and generate cell pool
07/11/2002US20020090383 Phosphatidyl oligoglycerols
07/11/2002US20020090382 Antiviral compounds and methods
07/11/2002US20020090376 Administering to the animal bacterial cells having a mutated poxR gene for inducing immune response in animal
07/11/2002US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
07/11/2002US20020090371 Orally or enterally administering to the mammal an effective immunosuppressive dose of a plant material derived from a plant transformant capable of producing antigen or an immunosuppressive fragment or its derivative
07/11/2002US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products
07/11/2002US20020090362 Immunotherapy using cytotoxic t lymphocytes (ctl)
07/11/2002US20020090361 Introducing into eukaryotic cell recombinase and at single-stranded targeting polynucleotides which have complementary and having homology clamp that corresponds to or is complementary to preselected target DNA sequence
07/11/2002US20020090355 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene
07/11/2002US20020090320 Provides flexibility, robustness, accuracy
07/11/2002US20020089005 Ferroelectric storage read-write memory
07/11/2002DE10064870A1 Schwefelhaltige Amphiphile für den Transfer von biologisch aktiven Molekülen in Zellen Sulfur-containing amphiphiles for the transfer of biologically active molecules into cells
07/11/2002DE10063048A1 Einzelketten-Antikörper mit verbesserter Stabilität Single-chain antibody with improved stability
07/11/2002DE10062302A1 Sekretionssignalpeptide, deren DNA-Sequenzen, damit herstellbare Expressionsvektoren für eukaryotische Zellen und deren Verwendung zur biotechnologischen Herstellung von Proteinen Secretion signal peptides, the DNA sequences can be produced so that expression vectors for eukaryotic cells and their use for the biotechnological production of proteins
07/11/2002DE10061864A1 Rekombinante Schweineleberesterase, deren Verwendung sowie ein Verfahren zu deren Herstellung Recombinant porcine liver esterase, to their use and to a process for their preparation
07/11/2002CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use
07/11/2002CA2558640A1 Spliceosome mediated rna trans-splicing
07/11/2002CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto
07/11/2002CA2434120A1 Detection of pathogenic bacteria
07/11/2002CA2434118A1 Spliceosome mediated rna trans-splicing
07/11/2002CA2433800A1 Antibodies to insulin-like growth factor i receptor
07/11/2002CA2433782A1 Proteins and nucleic acids encoding same
07/11/2002CA2433754A1 Alpha synuclein aggregation assays
07/11/2002CA2433749A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
07/11/2002CA2433674A1 Method for relative quantification of attached nucleic acids
07/11/2002CA2433620A1 Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof
07/11/2002CA2433606A1 Amphipathic peptides and their use for transferring substances of interest into cells
07/11/2002CA2433579A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
07/11/2002CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/11/2002CA2433534A1 Process for producing prenyl alcohol
07/11/2002CA2433529A1 Process for producing prenyl alcohol
07/11/2002CA2433526A1 Process for producing prenyl alcohol
07/11/2002CA2433492A1 Transcription activation complex comprising arnt 1 to 3 and a transcriptional regulatory factor and uses thereof
07/11/2002CA2433430A1 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family
07/11/2002CA2433250A1 Low-lipoxygenase 1 barley
07/11/2002CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
07/11/2002CA2433176A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
07/11/2002CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty
07/11/2002CA2432902A1 Gene disruption methodologies for drug target discovery
07/11/2002CA2432426A1 Recombinant protective protein from streptococcus pneumoniae
07/11/2002CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression
07/11/2002CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
07/11/2002CA2428932A1 Neuropilin homolog zcub5
07/10/2002EP1221491A1 SUSPENSION SYSTEM FOR SEQUENCING GENETIC SUBSTANCE, METHOD OF SEQUENCING GENETIC SUBSTANCE BY USING THE SUSPENSION SYSTEM, AND METHOD OF HIGH-SPEED SNPs SCORING BY USING THE SUSPENSION SYSTEM
07/10/2002EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
07/10/2002EP1221489A1 Regulatory sequences functioning in filamentous fungi
07/10/2002EP1221488A1 Stress proteins and uses therefor
07/10/2002EP1221487A2 Polynucleotide molecules encoding neospora proteins
07/10/2002EP1221486A2 Polynucleotide molecules encoding neospora proteins
07/10/2002EP1221485A2 Polynucleotide molecules encoding neospora proteins
07/10/2002EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them
07/10/2002EP1221483A1 NF-AT polypeptides and polynucleotides
07/10/2002EP1221482A1 Novel hemopoietin receptor protein, nr12
07/10/2002EP1221478A2 Polynucleotides coding for the type III, II and I erythrose reductases from Trichosporonoides megachilensis and uses thereof for the production of erythritol
07/10/2002EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination
07/10/2002EP1221317A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
07/10/2002EP1221283A2 Transgenic animal for screening therapeutic agents for brain tumors
07/10/2002EP1221050A2 Biomolecular attachment sites on microelectronic arrays
07/10/2002EP1221047A1 Addressable arrays using morphology dependent resonance for analyte detection
07/10/2002EP1220954A2 Nucleic acid primers and probes for detecting tumor cells
07/10/2002EP1220953A2 Template-dependent ligation with pna-dna chimeric probes
07/10/2002EP1220952A2 Converting diploidy to haploidy for genetic diagnosis
07/10/2002EP1220950A2 Genetic markers of toxicity, preparation and uses thereof
07/10/2002EP1220949A2 Chromosome-wide analysis of protein-dna interactions
07/10/2002EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
07/10/2002EP1220947A2 50 human secreted proteins
07/10/2002EP1220946A2 Methods of utilizing the tt virus
07/10/2002EP1220944A1 Nuclease inhibitor cocktail
07/10/2002EP1220943A2 Stable expression of polymorphous forms of human cytochrome p450 2d6 as an analytic in the pre-clinical development of medicaments